Crosser cleared for CTOs
This article was originally published in The Gray Sheet
Executive Summary
FlowCardia will launch its Crosser 14 high frequency ultrasound crossing catheter in the United States within the quarter, according to Director of Marketing Mark Page. The firm announced 510(k) clearance for the device, which uses a vibrating tip to facilitate guidewire passage through coronary chronic total occlusions, on Jan. 23. FlowCardia also announced Jan. 25 that three Crosser devices for peripheral CTOs were approved in Europe. Firms have struggled to enter the coronary CTO market with specialty devices (1"The Gray Sheet" March 6, 2006, p. 13)...